Terms: = Endocrine gland cancer AND CHD4, Mi2-BETA, 1108, ENSG00000111642, Mi-2b, DKFZp686E06161, Q14839 AND Prognosis
6 results:
1. The epigenetic factor chd4 contributes to metastasis by regulating the EZH2/β-catenin axis and acts as a therapeutic target in ovarian cancer.
Wang J; Zhong F; Li J; Yue H; Li W; Lu X
J Transl Med; 2023 Jan; 21(1):38. PubMed ID: 36681835
[TBL] [Abstract] [Full Text] [Related]
2. Identification of Prognostic Biomarkers in Papillary Thyroid cancer and Developing Non-Invasive Diagnostic Models Through Integrated Bioinformatics Analysis.
Oskouie AA; Ahmadi MS; Taherkhani A
Microrna; 2022; 11(1):73-87. PubMed ID: 35068400
[TBL] [Abstract] [Full Text] [Related]
3. Whole-Exome Sequencing of Matched Primary and Metastatic Papillary Thyroid cancer.
Masoodi T; Siraj AK; Siraj S; Azam S; Qadri Z; Albalawy WN; Parvathareddy SK; Al-Sobhi SS; Al-Dayel F; Alkuraya FS; Al-Kuraya KS
Thyroid; 2020 Jan; 30(1):42-56. PubMed ID: 31668133
[No Abstract] [Full Text] [Related]
4. High Expression of miR-532-5p, a Tumor Suppressor, Leads to Better prognosis in Ovarian cancer Both In Vivo and In Vitro.
Wang F; Chang JT; Kao CJ; Huang RS
Mol Cancer Ther; 2016 May; 15(5):1123-31. PubMed ID: 26873729
[TBL] [Abstract] [Full Text] [Related]
5. History before diagnosis in childhood craniopharyngioma: associations with initial presentation and long-term prognosis.
Hoffmann A; Boekhoff S; Gebhardt U; Sterkenburg AS; Daubenbüchel AM; Eveslage M; Müller HL
Eur J Endocrinol; 2015 Dec; 173(6):853-62. PubMed ID: 26392473
[TBL] [Abstract] [Full Text] [Related]
6. [Relationship between hormone therapy in women with ovarian malignancy and prognosis].
Li L; Pan ZM; Chen XQ; Gao K; Zhang W; Luo Y; Yao ZQ; Liang XQ; Huang W; Yao DS
Zhonghua Fu Chan Ke Za Zhi; 2008 Nov; 43(11):843-8. PubMed ID: 19087569
[TBL] [Abstract] [Full Text] [Related]
